Recent announcements indicate innovative technologies may provide new clinical solutions for the 36.9 million people living with HIV/AIDS worldwide.
The current standard of care for these people of all ages is a combination of antiretroviral therapies, which may control the disease, but are not curative, as they cannot target integrated HIV-1 genomes, says HIV.gov.
Recently, a potential cure for human immunodeficiency virus type 1 (HIV-1) created with CRISPR-based editing of HIV proviral DNA was announced.
Read More
